Order Article Reprints

Parriott JE, Stewart JP, Smith DD, Curran SM, Bauer CD, Wyatt TA, Phillips JA, Lyden E, Thiele GM, Vetro JA. Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization. Pharmaceutics. 2022; 14(9):1843. https://doi.org/10.3390/pharmaceutics14091843

Parriott, Jacob E., Jason P. Stewart, D. David Smith, Stephen M. Curran, Christopher D. Bauer, Todd A. Wyatt, Joy A. Phillips, Elizabeth Lyden, Geoffrey M. Thiele, and Joseph A. Vetro. 2022. "Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization" Pharmaceutics 14, no. 9: 1843. https://doi.org/10.3390/pharmaceutics14091843

Parriott, J. E., Stewart, J. P., Smith, D. D., Curran, S. M., Bauer, C. D., Wyatt, T. A., Phillips, J. A., Lyden, E., Thiele, G. M., & Vetro, J. A. (2022). Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization. Pharmaceutics, 14(9), 1843. https://doi.org/10.3390/pharmaceutics14091843